BAP1 and Miyoshi myopathy: The fact that mRNA profiling data in human sporadic MMs and MM carriers of germline BAP1 mutations show immune signatures similar to those observed in our mouse model suggest that the findings presented here have clinical relevance and potential therapeutic implications.